Dr. Basu's research focuses on methods and applications that study observed and unobserved heterogeneity in clinical and economic outcomes and attempts to establish the value of individualized care. Using micro-econometric theory and models, Dr. Basu strives to conduct health economic evaluations that are in line with public policy decision making. Dr. Basu has extensive experience in using innovative methods in comparative effectiveness and cost-effectiveness research. He has written extensively on modeling health expenditure data and the use of econometric methods for causal inference. He has also worked on the theoretical and empirical foundations in cost-effectiveness analyses and value of information analyses in the context of prostate cancer and schizophrenia.
Some of his work include establishing the value of individualized care based on patient preferences, developing models to predict quality of life of patients with multiple comorbidities, measuring the effect of patients' health on the quality of life of their partners,estimating the future value of research in diagnosing and finding a cure for Duchenne muscular dystrophy, developing simulation models for evaluating the cost-effectiveness of pharmacological treatment algorithms in schizophrenia, and comparative effectiveness research on the dynamic intensification of glucose lowering therapies in diabetes.
Dr. Basu is the recipient of numerous awards, including the NARSAD Wodecroft Young Investigator Award for his work on modeling the long-term risk of diabetes and cardiovascular disease due to atypical antipsychotics medications in patients with schizophrenia, the 2007 Research Excellence Award for Methodological Excellence and the 2009 Bernie O'Brien New Investigator Award from the International Society for Pharmacoeconomics and Outcomes Research, the 2008 Alan Williams Health Economics Fellowship from the University of York, UK and the 2009 Labelle Lectureship from McMaster University, Canada. Dr. Basu was a faculty at the University of Chicago from 2004-2010.
ANIRBAN BASU, PhD
(MS Biostatistics, UNC- Chapel Hill, PhD Public Policy (Health Economics), University of Chicago)
Department of Health Services, School of Public Health
Pharmaceutical Outcomes Research and Policy Program
Department of Economics
University of Washington, Seattle.
Faculty Research Fellow
National Bureau of Economic Research, Cambridge, MA.
Program in Health Economics and Outcomes Methodology (PHEnOM)
1959 NE Pacific St, Box 357660
Magnuson Health Sciences Center, Room H-694
Seattle, WA, 98195-7660
basua <at> uw.edu Tel: (206) 616-2986 Fax: (206) 543-3964